Safety and Efficacy of Empagliflozin and Diuretic Use in Patients with Heart Failure and Preserved Ejection Fraction: A Post Hoc Analysis of the EMPEROR-Preserved Trial

IMPORTANCE: The diuretic effect of sodium-glucose cotransporter 2 inhibitors may result in interaction with background diuretic therapy in patients with heart failure and preserved ejection fraction (HFpEF). OBJECTIVE: To assess the safety and efficacy of empagliflozin in combination with background...

Descripción completa

Detalles Bibliográficos
Autores principales: Butler, Javed, Usman, Muhammad Shariq, Filippatos, Gerasimos, Ferreira, João Pedro, Böhm, Michael, Brueckmann, Martina, Januzzi, James L., Kaul, Sanjay, Piña, Ileana L., Ponikowski, Piotr, Senni, Michele, Sumin, Mikhail, Verma, Subodh, Zaremba-Pechmann, Liliana, Pocock, Stuart J., Packer, Milton, Anker, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209829/
https://www.ncbi.nlm.nih.gov/pubmed/37223933
http://dx.doi.org/10.1001/jamacardio.2023.1090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10209829/
https://www.ncbi.nlm.nih.gov/pubmed/37223933
http://dx.doi.org/10.1001/jamacardio.2023.1090

Ejemplares similares